biobuzz

Raleigh’s Parexel Spotlights Site Partnerships and Honors Emerging Research Sites at the 2026 SCRS Global Site Solutions Summit

Parexel, a Raleigh, North Carolina-based global clinical development partner, announced it would lead discussions on site activation and engagement and recognize emerging research sites at the 2026 ...
biobuzz

SAS and NC State Launch AI Think & Do Tank Focused on Predicting How Treatments Behave in Humans

SAS, the Cary, North Carolina, data and AI software company, and North Carolina State University announced on October 1, 2026 the SAS Think & Do Tank, a research partnership that embeds SAS’ data, AI ...
biobuzz

Maryland, Virginia Life Sciences News: Georgiamune–Menarini Deal, SOAR Bio $600K & More

Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s ...
biobuzz

LabConnect and Korea’s GCCL Sign MOU to Coordinate Multi-Regional Clinical Trials

Raleigh-based central laboratory company LabConnect has signed a memorandum of understanding (MOU) with GCCL, a South Korean clinical trial sample analysis lab, to work together on global studies that ...
biobuzz

Brii Biosciences Launches BRiSC™, a Dual-Targeting siRNA Discovery Platform

Brii Biosciences, a Hong Kong-listed biotechnology company with U.S. operations in Durham, North Carolina, announced on October 15, 2026 that it has launched BRiSC™ (Bispecific RNAi SilenCing), its in ...
biobuzz

People on the Move: Stephen Brannan and John Young Join Slate Medicines as Board Members

The transition from an early-stage pipeline to late-stage clinical execution fundamentally changes the problems a biotechnology company has to solve. For Slate Medicines, a Raleigh, North ...
biobuzz

North Carolina

Learn effective strategies to expedite your IND-enabling studies. Discover how to efficiently and effectively streamline and schedule preclinical studies to meet your regulatory submission milestone.
biobuzz

People on the Move: Roger Lias Named Head of Commercial at Bora Biologics

Bora Biologics has named Roger Lias, Ph.D., as Head of Commercial, where he will lead the company’s global commercial activities. Lias will focus on understanding each customer’s program and ...
biobuzz

People on the Move: David Rubenstein Named Chief Scientist at Adial Pharmaceuticals

Adial Pharmaceuticals has appointed David Rubenstein, M.D., Ph.D., as Chief Scientist, where he will lead the Glen Allen, Virginia-based company’s research and scientific strategy. Rubenstein will ...
biobuzz

Gaithersburg’s Georgiamune Signs Potential $1.1 Billion Global Cancer Drug Licensing Deal With Menarini

Georgiamune has signed an exclusive worldwide licensing and collaboration agreement with Italy’s Menarini Group for GIM-621, an experimental oral cancer immunotherapy. Georgiamune is set to receive ...
biobuzz

Fortrea Closes $45 Million Deal for Worldwide Clinical Trials’ Early Phase Division

Fortrea, the Durham, North Carolina-based contract research organization (CRO), announced on October 19, 2026 that it has finished buying the Early Phase Services division of Worldwide Clinical Trials ...
biobuzz

Immunocore Doses First Patient in Phase 1 Trial of IMC-S118AI, Its First Tissue-Specific Autoimmune Candidate, for Type 1 Diabetes

Immunocore (Nasdaq: IMCR), a commercial-stage biotechnology company with U.S. operations in Radnor, Pennsylvania, and Gaithersburg, Maryland, announced on October 15, 2026 that the first patient with ...